Pioglitazone-containing Medicines: Drug Safety Communication - Updated FDA Review, Increased Risk of Bladder Cancer
FDA approved label updates to describe additional studies reviewed.
FDA approved label updates to describe additional studies reviewed.
80.211.154.110